Formulation development of physiological environment responsive periodontal drug delivery system for local delviery of metronidazole benzoate

References

• Steinberg S, Michael F. (1988). Drug delivery devices: Fundamentals and applications. In:Tyles P, ed. New York: Marcel Dekker Inc., 492–515.
   Google Scholar
• Becker W, Berg L, Becker BE. (1979). Untreated periodontal disease: a longitudinal study. J Periodontol, 50:234–244.
   PubMed Web of Science ®Google Scholar
• Pitcher GR, Newman HN, Strahan JD. (1980). Access to subgingival plaque by disclosing agents using mouthrinsing and direct irrigation. J Clin Periodontol, 7:300–308.
   PubMed Web of Science ®Google Scholar
• Greenstein G. (1987). Effects of subgingival irrigation on periodontal status. J Periodontol, 58:827–836.
   PubMed Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Djokic J, Coulter WA. (1996). Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res, 13:1734–1738.
   PubMed Web of Science ®Google Scholar
• Olsvik B. (1991). [Tetracycline resistance in oral microorganisms in patients with periodontal disease]. Nor Tannlaegeforen Tid, 101:50–52.
   PubMedGoogle Scholar
• Vandekerckhove BN, Quirynen M, van Steenberghe D. (1997). The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis. J Periodontol, 68:353–361.
   PubMed Web of Science ®Google Scholar
• Slots J, Pallasch TJ. (1996). Dentists’ role in halting antimicrobial resistance. J Dent Res, 75:1338–1341.
   PubMed Web of Science ®Google Scholar
• Loesche WJ. (1996). Antimicrobials in dentistry: with knowledge comes responsibility. J Dent Res, 75:1432–1433.
   PubMed Web of Science ®Google Scholar
• Listgarten MA. (1987). Nature of periodontal diseases: pathogenic mechanisms. J Periodont Res, 22:172–178.
   PubMed Web of Science ®Google Scholar
• Slots J, Mashimo P, Levine MJ, Genco RJ. (1979). Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy. J Periodontol, 50:495–509.
   PubMed Web of Science ®Google Scholar
• Lindhe J, Liljenberg B, Adielsson B. (1983). Effect of long-term tetracycline therapy on human periodontal disease. J Clin Periodontol, 10:590–601.
   PubMed Web of Science ®Google Scholar
• Ellen RP, McCulloch CA. (1996). Evidence versus empiricism: rational use of systemic antimicrobial agents for treatment of periodontitis. Periodontol 2000, 10:29–44.
   PubMed Web of Science ®Google Scholar
• Southard GL, Godowski KC. (1998). Subgingival controlled release of antimicrobial agents in the treatment of periodontal disease. Int J Antimicrob Agents, 9:239–253.
   PubMed Web of Science ®Google Scholar
• Schwach-Abdellaoui K, Loup PJ, Vivien-Castioni N, Mombelli A, Baehni P, Barr J et al. (2002). Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: preliminary trial in humans. AAPS PharmSci, 4:E20.
   PubMedGoogle Scholar
• Jones DS, Woolfson AD, Brown AF, Coulter WA, McClelland C, Irwin CR. (2000). Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release, 67:357–368.
   PubMed Web of Science ®Google Scholar
• Arica B, Aksungur P, Fienel S, Kafl HS, Sargon MF, Hincal AA. (2003). Natamycin loaded chitosan microspheres for periodontal therapy. J of the Faculty of Pharmacy, 23:77–84.
   Google Scholar
• Vert M, Schwach G, Engel R, Coudane J. (1998). Something new in the field of PLA/GA bioresorbable polymers? J Control Release, 53:85–92.
   PubMed Web of Science ®Google Scholar
• Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. (1999). Polymeric systems for controlled drug release. Chem Rev, 99:3181–3198.
   PubMed Web of Science ®Google Scholar
• Jain RA. (2000). The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 21:2475–2490.
   PubMed Web of Science ®Google Scholar
• Koleske JV. (1978). Blends containing polycaprolactone and related polymers. In: D.R. Paul, Newman S, ed. Polymer Blends. New York: Academic Press, 369.
   Google Scholar
• Aslan S, Calandrelli LP, Laurienzo M, Malinconico C. (2000). Poly (D,L-lactic acid)/ polycaprolactone) blend membranes: preparation and morphological characterization. J Mater Sci, 35:1615–1622.
   Web of Science ®Google Scholar
• Chena CC, Chueha JY, Tsengb HM, Huang SY. (2003). Preparation and characterization of biodegradable PLA polymeric blends. Biomaterials, 24:1167–1173.
   PubMed Web of Science ®Google Scholar
• Zhidong L, Jiawei L, Shufang N, Hui L, Pingtian D, Weisan P. (2006). Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm, 315:12–17.
   PubMedGoogle Scholar
• Balasubramaniam J, Kant S, Pandit JK. (2003). In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. Acta Pharm, 53:251–261.
   PubMedGoogle Scholar
• Reddy GT, Kumar TM, Veena.(2005). Formulation and evaluation of Alendronate Sodium gel for the treatment of bone resorptive lesions in Periodontitis. Drug Deliv, 12:217–222.
   PubMed Web of Science ®Google Scholar
• Graves RA, Freeman T, Mandal TK. (2007). In vitro dissolution method for evaluation of buprenorphine in situ gel formulation: a technical note. AAPS PharmSciTech, 8:E62.
   PubMed Web of Science ®Google Scholar
• El-Kamel AH, Ashri LY, Alsarra IA. (2007). Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases. AAPS Pharm Sci Tech, 8:E75.
   PubMedGoogle Scholar
• Dabhi MR, Nagori SA, Gohel MC, Parikh RK, Sheth NR. (2010). Formulation development of smart gel periodontal drug delivery system for local delivery of chemotherapeutic agents with application of experimental design. Drug Deliv, 17:520–531.
   PubMed Web of Science ®Google Scholar
• Kodym A, Kaczynska-Dyba E, Kubiak B, Kukula H. (2011). Technology of eye drops containing metronidazole. Acta Pol Pharm, 68:109–114.
   PubMed Web of Science ®Google Scholar
• El-Kamel A, Al-Dosari H, Al-Jenoobi F. (2006). Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. Drug Deliv, 13:55–59.
   PubMed Web of Science ®Google Scholar
• Cohen S, Lobel E. (1997). A novel in situ forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J Cont Rel, 44:201–208.
   Web of Science ®Google Scholar
• Schwartz JB, Simonelli AP, Higuchi WI. (1968). Drug release from wax matrices. I. Analysis of data with first-order kinetics and with the diffusion-controlled model.. J Pharm Sci, 57:274–277.
   PubMed Web of Science ®Google Scholar
• Günzler H, Gremlich HU. (2002). IR spectroscopy - an introduction.Weinheim: WILEY-VCH, 3, 4, 193, 196, 208, 217, 221, 230, 233, 235.
   Google Scholar
• Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB, Aminabhavi TM. (2007). Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(ϵ-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: In vitro and in vivo studies. J Cont Rel, 119:59–68.
   PubMed Web of Science ®Google Scholar